Anika Therapeutics (ANIK) News
NASDAQ: ANIKHealth CareMedical/Dental InstrumentsUSD
19.58+0.35 (+1.82%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ANIK news summary
We found 2 recent headlines mentioning Anika Therapeutics (ANIK): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, ANIK is up 1.82% at $19.58. The most recent story, "NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication", was published by Nasdaq on Sep 21, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Anika Therapeutics headlines
- NVS Gets Positive CHMP Opinion for Cosentyx for Another IndicationNVS' Cosentyx wins a positive EU opinion for PMR, backed by late-stage data, potentially expanding its use beyond existing inflammatory conditions.NasdaqNVS, RGEN, ANIK, IONS
- IQV Stock Gains 42% in 3 Months: Here's What You Should KnowIQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.NasdaqIQV, ANIK, BTSG